IDRA News and Press, Idera Pharmaceuticals Inc. From 08/04/20

Idera Pharmaceuticals (NASDAQ: IDRA ) : Q2 GAAP EPS of -$0.72 misses by $0.33 . More news on: Idera Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

EXTON, Pa., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera” or the “Company”) (Nasdaq: IDRA) today reported its financial and operational results for the second quarter ended June 30, 2020. “Idera meaningfully advanced its clinica...

Quick Take Checkmate Pharmaceuticals ( CMPI ) intends to raise $75 million from the sale of its common stock stock in an IPO, according to an amended registration statement . The company is advancing a biologic particle treatment for melanomas and head & neck squamous cell carcinomas....

Quick Take Checkmate Pharmaceuticals ( CMPI ) has filed to raise $75 million in an IPO of its common stock, according to an S-1 registration statement . The company is a clinical stage biopharma advancing a drug treatment candidate for melanoma and head & neck cancer. CMPI has produ...

DPW Holdings (NYSEMKT: DPW )   +136%  on introducing a new product line of electric vehicle chargers. More news on: DPW Holdings, Inc., Sonnet BioTherapeutics Holdings, Inc., Volt Information Sciences, Inc., Stocks on the move, , Read more ...

Idera Pharmaceuticals (NASDAQ: IDRA ) inks agreements with institutional investors for sale of common shares and warrants to purchase an additional shares of common stock, in a private placement, for gross proceeds of $5.1M (Tranche 1). The combined purchase price is $1.845. More news ...

EXTON, Pa., July 15, 2020 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced entering into an agreement with a fund affiliated with institutional investors providing for a private placement exempt from the registration requirements of the Securities Act of 1933, ...

Westwater Resources (NASDAQ: WWR ) +144%  on positive independent test results on ULTRA-PMG. More news on: Westwater Resources, Inc., Tenax Therapeutics, Inc., BioHiTech Global, Inc., Stocks on the move, , Read more ...

Thinly traded nano cap Idera Pharmaceuticals (NASDAQ: IDRA ) jumps  17%  premarket on increased volume in reaction to preliminary data from an open-label Phase 2 clinical trial, ILLUMINATE-206 , evaluating tilsotolimod, combined with Bristol Myers Squibb's (NYSE: BMY ) Opdivo (n...

EXTON, Pa., June 02, 2020 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA; the “Company”) today announced preliminary data from the first 10 patients in the safety cohort of  ILLUMINATE-206, a Phase 2, open-label, multi-center study to evaluate tilsotolimod ...